Rep profile
Rep profile
Kathy Headley
company
Astra USA Inc.
Title
Professional Sales Representative
current home
Jacksonsville, FL
Territory: Southern Georgia and Jacksonville, Florida.
Customers: Cardiologists, allergists, pulmonologists, family practitioners, general practitioners, internal medicine and pediatricians.
Sales techniques "I have to believe in my products in order to sell them. I tell the physicians the pros and cons of a product. I also build relationships with the office staff, not just the physicians. I educate everyone in the office about my product. Finally, I listen to the needs of the office."
Motivation: "I like meeting different people and experiencing different personalities. I enjoy meeting with a variety of offices and traveling to see them. Success stories are wonderful to hear. It's nice to know that my products are working for physicians and patients."
Seeing "no sees:" "I am consistent but not aggressive. I try to think of creative ways to get the physician's attention. One physician hadn't seen a rep in 20 years. I sent back a piece of a heart model and attached a note that read, 'Don't break my heart.' The physician was so amused that he let me in to see him. I've called on him a couple of times since then."
Volunteer work: "I sponsor a 13-year-old girl through the Baptist Home for Children, an orphanage in Jacksonville, FL. I enjoy spending time with her and knowing that I am making a difference. I am also the activities chairperson for my church. Many of the office staffs I visit have become interested in volunteer work for a variety of organizations. Physicians are always letting me know about a charity or an organization looking for volunteers."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.